Similar articles

• [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].

  Carbonell Masía DC, Calvé Pérez A. Carbonell Masía DC, et al. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1976 Nov-Dec;4(6):377-86. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1976. PMID: 19933 Clinical Trial. Spanish. No abstract available.
• [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].

  Radmayr E, Koeppen D. Radmayr E, et al. MMW Munch Med Wochenschr. 1977 Dec 16;119(50):1623-6. MMW Munch Med Wochenschr. 1977. PMID: 23493 Clinical Trial. German.
• [Controlled trial using pinazepam in subjects with endocrine diseases].

  Menchini Fabris F, Bianchi B, Berni GL, Mariani M. Menchini Fabris F, et al. Clin Ter. 1976 Jun 30;77(6):543-51. Clin Ter. 1976. PMID: 12903 Clinical Trial. Italian. No abstract available.
• Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review.

  Solomon K, Hart R. Solomon K, et al. J Clin Psychiatry. 1978 Nov;39(11):823-31. J Clin Psychiatry. 1978. PMID: 31354 Review.
• The design of drug trials with neurotic patients.

  Kellner R. Kellner R. Behav Neuropsychiatry. 1970 Apr-May;2(1):12-9. Behav Neuropsychiatry. 1970. PMID: 4913956 Review. No abstract available.